Cart
sales@molnova.com
Clevudine
CAS No. 163252-36-6
Clevudine( Clevudine | L-FMAU | L FMAU | LFMAU )
Catalog No. M12457 CAS No. 163252-36-6
Clevudine is an antiviral drug for the treatment of hepatitis B.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 30 | In Stock |
|
| 5MG | 42 | In Stock |
|
| 10MG | 65 | In Stock |
|
| 25MG | 115 | In Stock |
|
| 50MG | 186 | In Stock |
|
| 100MG | 332 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameClevudine
-
NoteResearch use only, not for human use.
-
Brief DescriptionClevudine is an antiviral drug for the treatment of hepatitis B.
-
DescriptionClevudine is an antiviral drug for the treatment of hepatitis B.(In Vitro):Clevudine (L-FMAU) shows some activity against Epstein-Barr virus.
-
In VitroClevudine (L-FMAU) shows some activity against Epstein-Barr virus.
-
In Vivo——
-
SynonymsClevudine | L-FMAU | L FMAU | LFMAU
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA polymerase| RNA polymerase
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number163252-36-6
-
Formula Weight260.22
-
Molecular FormulaC10H13FN2O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:52 mg/mL (199.83 mM); Ethanol:4 mg/mL (15.37 mM); Water:52 mg/mL (199.83 mM)
-
SMILESO=C1NC(C(C)=CN1[C@@H]2[C@H](F)[C@H]([C@H](CO)O2)O)=O
-
Chemical Name1-((2S,3R,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chong Y, et al. Bioorg Med Chem Lett, 2002, 12(23), 3459-3462.
molnova catalog
related products
-
Emzadirib
Emzadirib (RAD51-IN-2) is a potent inhibitor of RAD51, showing potential anticancer activity and useful for studying DNA damage repair.
-
SMN-C3
SMN-C3 (MV8T2MCK57) is an orally active modulator of SMN2 splicing, and has the potential to treat spinal muscular atrophy (SMA).
-
Compound 3A
Compound 3A can effectively inhibit the transcription of RNA polymerase I in the A375 malignant melanoma cell line but has no effect on polymerase II.
